Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Petrie JR"'
Autor:
Yang, Z, MacDonald-Dunlop, E, Chen, J, Zhai, R, Li, T, Richmond, A, Klaric, L, Pirastu, N, Ning, Z, Zheng, C, Wang, Y, Huang, T, He, Y, Guo, H, Ying, K, Gustafsson, S, Prins, B, Ramisch, A, Dermitzakis, ET, Png, G, Eriksson, N, Haessler, J, Hu, X, Zanetti, D, Boutin, T, Hwang, S-J, Wheeler, E, Pietzner, M, Raffield, LM, Kalnapenkis, A, Peters, JE, Viñuela, A, Gilly, A, Elmståhl, S, Dedoussis, G, Petrie, JR, Polašek, O, Folkersen, L, Chen, Y, Yao, C, Võsa, U, Pairo-Castineira, E, Clohisey, S, Bretherick, AD, Rawlik, K, Esko, T, Enroth, S, Johansson, Å, Gyllensten, U, Langenberg, C, Levy, D, Hayward, C, Assimes, TL, Kooperberg, C, Manichaikul, AW, Siegbahn, A, Wallentin, L, Lind, L, Zeggini, E, Schwenk, JM, Butterworth, AS, Michaëlsson, K, Pawitan, Y, Joshi, PK, Baillie, JK, Mälarstig, A, Reiner, AP, Wilson, JF, Shen, X, GenOMICC Consortium and the IMI-DIRECT Consortium
Publikováno v:
2022, ' Genetic Landscape of the ACE2 Coronavirus Receptor ', Circulation, vol. 145, no. 18, pp. 1398-1411 . https://doi.org/10.1161/CIRCULATIONAHA.121.057888
Background: SARS-CoV-2, the causal agent of COVID-19, enters human cells using the ACE2 (angiotensin-converting enzyme 2) protein as a receptor. ACE2 is thus key to the infection and treatment of the coronavirus. ACE2 is highly expressed in the heart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0128f78af77cf151b26041b84787ced5
http://hdl.handle.net/10044/1/96467
http://hdl.handle.net/10044/1/96467
Autor:
Tack, CJ, Jacob, S, Desouza, C, Bain, SC, Buse, JB, Nauck, MA, Petrie, JR, Poulter, NR, Pratley, RE, Stegmann, HVBK, Bosch-Traberg, H, Startseva, E, Zinman, B, LEADER Publication Committee on behalf of the LEADER Trial Investigators
Publikováno v:
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism, 21, 2450-2458
Diabetes, Obesity & Metabolism, 21, 11, pp. 2450-2458
Diabetes, Obesity & Metabolism, 21, 2450-2458
Diabetes, Obesity & Metabolism, 21, 11, pp. 2450-2458
Contains fulltext : 215463.pdf (Publisher’s version ) (Open Access) AIM: Glucagon-like peptide-1 receptor agonist (GLP-1RA) and insulin combination therapy is an effective treatment option for type 2 diabetes, but long-term data are lacking. The ai
Autor:
Petrie, JR, Boyle, JG
Publikováno v:
In Davidson's Principles and Practice of Medicine Edition: 24th Edition. 2023:703-753
Autor:
Trico, D, Mengozzi, A, Nesti, L, Hatunic, M, Sanchez, Rg, Konrad, T, Lalic, K, Lalic, Nm, Mari, A, Natali, A, Heine, Rj, Dekker, J, de Rooij, S, Nijpels, G, Boorsma, W, Mitrakou, A, Tournis, S, Kyriakopoulou, K, Thomakos, P, Lalic, N, Jotic, A, Lukic, L, Civcic, M, Nolan, J, Yeow, Tp, Murphy, M, Delong, C, Neary, G, Colgan, Mp, Bohles, H, Fuellert, S, Baer, F, Zuchhold, H, Golay, A, Bobbioni, Eh, Barthassat, V, Makoundou, V, Lehmann, Tno, Merminod, T, Petrie, Jr, Perry, C, Neary, F, Macdougall, C, Shields, K, Malcolm, L, Laakso, M, Salmenniemi, U, Aura, A, Raisanen, R, Ruotsalainen, U, Sistonen, T, Laitinen, M, Saloranta, H, Coppack, Sw, Mcintosh, N, Ross, J, Pettersson, L, Khadobaksh, P, Laville, M, Bonnet, F, de la Perriere, Ab, Louche-Pelissier, C, Maitrepierre, C, Peyrat, J, Beltran, S, Serusclat, A, Gabriel, R, Sanchez, Em, Carraro, R, Friera, A, Novella, B, Nilsson, P, Persson, M, Ostling, G, Melander, O, Burri, P, Piatti, Pm, Monti, Ld, Setola, E, Galluccio, E, Minicucci, F, Colleluori, A, Walker, M, Ibrahim, I, Jayapaul, M, Carman, D, Ryan, C, Short, K, Mcgrady, Y, Richardson, D, Beck-Nielsen, H, Staehr, P, Hojlund, K, Vestergaard, V, Olsen, C, Hansen, L, Bolli, Gb, Porcellati, F, Fanelli, C, Lucidi, P, Calcinaro, F, Saturni, A, Ferrannini, E, Muscelli, E, Pinnola, S, Kozakova, M, Casolaro, A, Astiarraga, Bd, Mingrone, G, Guidone, C, Favuzzi, A, Di Rocco, P, Anderwald, C, Bischof, M, Promintzer, M, Krebs, M, Mandl, M, Hofer, A, Luger, A, Waldhausl, W, Roden, M, Balkau, B, Dekker, Jm, Petrie, J, Gaffney, P, Boran, G, Kok, A, Patel, S, Gastaldelli, A, Ciociaro, D, Guillanneuf, Mt, Mhamdi, L, Landucci, L, Hills, S, Mota, L, Pacini, G, Cavaggion, C, Tura, A, Hills, Sa, Mota, L.
Experimental studies suggest that the fatty acid palmitoleate may act as an adipocyte-derived lipid hormone (or ‘lipokine’) to regulate systemic metabolism. We investigated the relationship of circulating palmitoleate with insulin sensitivity, be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a93ee122ea33f1f61e1a1f0f99aec14a
http://hdl.handle.net/11382/530919
http://hdl.handle.net/11382/530919
Autor:
Nauck, Ma, Petrie, Jr, Sesti, G, Mannucci, E, Courrèges, Jp, Lindegaard, Ml, Jensen, Cb, Atkin, Sl, Study 1821 Principal, Investigators.
Publikováno v:
Diabetes Care. 39:231-241
OBJECTIVE To investigate the dose-response relationship of semaglutide versus placebo and open-label liraglutide in terms of glycemic control in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS This was a 12-week, randomized, double-blind p
Autor:
S. W. D. Hart, Cihangir Celik, Bradley T Rearden, Dorothea Wiarda, Douglas E. Peplow, William Bj J Marshall, Lester M Petrie Jr, Ahmad M. Ibrahim, Christopher M. Perfetti, Michael E Dunn, Kursat B. Bekar
Publikováno v:
Annals of Nuclear Energy. 82:130-141
SCALE is a widely used suite of tools for nuclear systems modeling and simulation that provides comprehensive, verified and validated, user-friendly capabilities for criticality safety, reactor physics, radiation shielding, and sensitivity and uncert
Autor:
Petrie, JR, Marso, SP, Bain, SC, Franek, E, Jacob, S, Masmiquel, L, Leiter, LA, Haluzik, M, Satman, I, Omar, M, Shestakova, M, Van Gaal, L, Mann, JF, Baeres, FM, Zinman, B, Poulter, NR, LEADER investigators
Publikováno v:
Journal of hypertension
Journal of Hypertension
Journal of Hypertension
Objective: As glucagon-like peptide-1 receptor agonists lower blood pressure (BP) in type 2 diabetes mellitus (T2DM), we examined BP control in relation to targets set by international bodies prior to randomization in the Liraglutide Effect and Actio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76bde80e35bc7f47df055c0d2b64ac39
https://eprints.gla.ac.uk/116246/1/116246.pdf
https://eprints.gla.ac.uk/116246/1/116246.pdf
Publikováno v:
Nuclear Technology. 174:214-235
This paper describes the Monte Carlo codes KENO V.a and KENO-VI in SCALE that are primarily used to calculate multiplication factors and flux distributions of fissile systems. Both codes allow explicit geometric representation of the target systems a
Autor:
de Rooij SR, Dekker, Jm, Kozakova, M, Mitrakou, A, Melander, O, Gabriel, R, Guidone, C, Højlund, K, Murphy, Ms, Nijpels, G, Dekker, J, de Rooij, S, Boorsma, P, Tournis, S, Kyriakopoulou, K, Thomakos, P, Lalic, N, Lalic, K, Jotic, A, Lukic, L, Civcic, M, Nolan, J, Yeow, Tp, Murphy, M, Delong, C, Neary, G, Colgan, Mp, Hatunic, M, Konrad, T, Böhles, H, Fuellert, S, Baer, F, Zuchhold, H, Golay, A, Harsch Bobbioni, E, Barthassat, V, Makoundou, V, Lehmann, Tn, Merminod, T, Petrie, Jr, Perry, C, Neary, F, Macdougall, C, Shields, K, Malcolm, L, Laakso, M, Salmenniemi, U, Aura, A, Raisanen, R, Raisanen, U, Sistonen, T, Laitinen, M, Saloranta, H, Coppack, Sw, Mcintosh, N, Ross, J, Pettersson, L, Khadobaksh, P, Laville, M, Bonnet, F, Brac de la Perriere, A, Louche Pelissier, C, Maitrepierre, C, Peyrat, J, Beltran, S, Serusclat, S, Sánchez, Me, Carraro, R, Friera, A, Perez, S, Nilsson, P, Persson, M, Ostling, G, Burri, P, Piatti, Pm, Monti, Ld, Setola, E, Galluccio, E, Minicucci, F, Colleluori, A, Walker, M, Ibrahim, Im, Jayapaul, M, Carman, D, Ryan, C, Short, K, Mcgrady, Y, Richardson, D, Beck Nielsen, H, Staehr, P, Hojlund, K, Vestergaard, V, Olsen, C, Hansen, L, Bolli, Gb, Porcellati, Francesca, Fanelli, Carmine Giuseppe, Lucidi, Paola, Calcinaro, F, Saturni, A, Ferrannini, E, Natali, A, Muscelli, E, Pinnola, S, Mingrone, G, Favuzzi, A, Di Rocco, P, Anderwald, C, Bischof, M, Promintzer, M, Krebs, M, Mandl, M, Hofe, A, Luger, A, Waldhäusl, W, Roden, M, Balkau, B, Mari, A, Gaffney, P, Boran, G, Kok, A, Patel, S, Gastaldelli, A, Ciociaro, D, Guillanneuf, Mt, Mhamdi, L, Landucci, L, Hills, S, Mota, L, Pacini, G, Cavaggion, C, Hills, Sa, Mota
Publikováno v:
de Rooij, S R, Dekker, J M, Kozakova, M, Mitrakou, A, Melander, O, Gabriel, R, Guidone, C, Hojlund, K, Murphy, M S & Nijpels, M G A A M 2009, ' Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study ', European Journal of Endocrinology, vol. 161, no. 2, pp. 223-230 . https://doi.org/10.1530/EJE-09-0058
European Journal of Endocrinology, 161(2), 223-230. BioScientifica Ltd.
de Rooij, S R, Dekker, J M, Kozakova, M, Mitrakou, A, Melander, O, Gabriel, R, Guidone, C, Højlund, K, Murphy, M S, Nijpels, G & Group, RISC 2009, ' Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study ', European Journal of Endocrinology, vol. 161, no. 2, pp. 223-30 . https://doi.org/10.1530/EJE-09-0058
European Journal of Endocrinology, 161(2), 223-230. BioScientifica Ltd.
de Rooij, S R, Dekker, J M, Kozakova, M, Mitrakou, A, Melander, O, Gabriel, R, Guidone, C, Højlund, K, Murphy, M S, Nijpels, G & Group, RISC 2009, ' Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study ', European Journal of Endocrinology, vol. 161, no. 2, pp. 223-30 . https://doi.org/10.1530/EJE-09-0058
ObjectiveFasting insulin concentrations are often used as a surrogate measure of insulin resistance. We investigated the relative contributions of fasting insulin and insulin resistance to cardiometabolic risk and preclinical atherosclerosis.Design a
Autor:
STRAWBRIDGE RJ, DUPUIS J, PROKOPENKO I, BARKER A, AHLQVIST E, RYBIN D, PETRIE JR, TRAVERS ME, BOUATIA-NAJI N, DIMAS AS, NICA A, WHEELER E, CHEN H, VOIGHT BF, TANEERA J, KANONI S, PEDEN JF, TURRINI F, GUSTAFSSON S, ZABENA C, ALMGREN P, BARKER DJ, BARNES D, DENNISON EM, ERIKSSON JG, ERIKSSON P, EURY E, FOLKERSEN L, FOX CS, FRAYLING TM, GOEL A, GU HF, HORIKOSHI M, ISOMAA B, JACKSON AU, JAMESON KA, KAJANTIE E, KERR-CONTE J, KUULASMAA T, KUUSISTO J, LOOS RJ, LUAN J, MAKRILAKIS K, MANNING AK, MARTÍNEZ-LARRAD MT, NARISU N, NASTASE MANNILA M, OHRVIK J, OSMOND C, PASCOE L, PAYNE F, SAYER AA, SENNBLAD B, SILVEIRA A, STANCÁKOVÁ A, STIRRUPS K, SWIFT AJ, SYVÄNEN AC, TUOMI T, VAN 'T HOOFT FM, WALKER M, WEEDON MN, XIE W, ZETHELIUS B, DIAGRAM CONSORTIUM, GIANT CONSORTIUM, MANUNTA P, MUTHER CONSORTIUM, CARDIOGRAM CONSORTIUM, C4D CONSORTIUM, ONGEN H, MÄLARSTIG A, HOPEWELL JC, SALEHEEN D, CHAMBERS J, PARISH S, DANESH J, KOONER J, OSTENSON CG, LIND L, COOPER CC, SERRANO-RÍOS M, FERRANNINI E, FORSEN TJ, CLARKE R, FRANZOSI MG, SEEDORF U, WATKINS H, FROGUEL P, JOHNSON P, DELOUKAS P, COLLINS FS, LAAKSO M, DERMITZAKIS ET, BOEHNKE M, MCCARTHY MI, WAREHAM NJ, GROOP L, PATTOU F, GLOYN AL, DEDOUSSIS GV, LYSSENKO V, MEIGS JB, BARROSO I, WATANABE RM, INGELSSON E, LANGENBERG C, HAMSTEN A, FLOREZ JC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::a21e1a5dd355ad0ad3f513cd88781bcb